Moreover, if elevated levels of circulating SPC+/GSDMD+ EVs also occur in preterm infants, they could be used as a predictive biomarker of BPD and possibly poor neurodevelopmental outcome. This evidence concerns the gene GSDMD and bronchopulmonary dysplasia.